The oldest unvaccinated Covid-19 survivors in South America.
The oldest unvaccinated Covid-19 survivors in South America.
复制标题
DOI:
10.1186/s12979-022-00310-y
复制
发表时间:
2022-11-16
影响因子:
7.9
通讯作者:
Zatz, Mayana
中科院分区:
文献类型:
--
作者:
de Castro, Mateus, V;Silva, Monize V. R.;Naslavsky, Michel S.;Scliar, Marilia O.;Nunes, Kelly;Passos-Bueno, Maria Rita;Castelli, Erick C.;Magawa, Jhosiene Y.;Adami, Flavia L.;Moretti, Ana I. S.;de Oliveira, Vivian L.;Boscardin, Silvia B.;Cunha-Neto, Edecio;Kalil, Jorge;Jouanguy, Emmanuelle;Bastard, Paul;Casanova, Jean-Laurent;Quinones-Vega, Mauricio;Sosa-Acosta, Patricia;de Guedes, Jessica S.;de Almeida, Natalia P.;Nogueira, Fabio C. S.;Domont, Gilberto B.;Santos, Keity S.;Zatz, Mayana
Although older adults are at a high risk of severe or critical Covid-19, there are many cases of unvaccinated centenarians who had a silent infection or recovered from mild or moderate Covid-19. We studied three Brazilian supercentenarians, older than 110 years, who survived Covid-19 in 2020 before being vaccinated. Despite their advanced age, humoral immune response analysis showed that these individuals displayed robust levels of IgG and neutralizing antibodies (NAbs) against SARS-CoV-2. Enrichment of plasma proteins and metabolites related to innate immune response and host defense was also observed. None presented autoantibodies (auto-Abs) to type I interferon (IFN). Furthermore, these supercentenarians do not carry rare variants in genes underlying the known inborn errors of immunity, including particular inborn errors of type I IFN. These observations suggest that their Covid-19 resilience might be a combination of their genetic background and their innate and adaptive immunity. The online version contains supplementary material available at 10.1186/s12979-022-00310-y.
登录
查看更多内容
DOI:
10.1126/science.abd4585
发表时间:
2020-10-23
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Bastard P;Rosen LB;Zhang Q;Michailidis E;Hoffmann HH;Zhang Y;Dorgham K;Philippot Q;Rosain J;Béziat V;Manry J;Shaw E;Haljasmägi L;Peterson P;Lorenzo L;Bizien L;Trouillet-Assant S;Dobbs K;de Jesus AA;Belot A;Kallaste A;Catherinot E;Tandjaoui-Lambiotte Y;Le Pen J;Kerner G;Bigio B;Seeleuthner Y;Yang R;Bolze A;Spaan AN;Delmonte OM;Abers MS;Aiuti A;Casari G;Lampasona V;Piemonti L;Ciceri F;Bilguvar K;Lifton RP;Vasse M;Smadja DM;Migaud M;Hadjadj J;Terrier B;Duffy D;Quintana-Murci L;van de Beek D;Roussel L;Vinh DC;Tangye SG;Haerynck F;Dalmau D;Martinez-Picado J;Brodin P;Nussenzweig MC;Boisson-Dupuis S;Rodríguez-Gallego C;Vogt G;Mogensen TH;Oler AJ;Gu J;Burbelo PD;Cohen JI;Biondi A;Bettini LR;D'Angio M;Bonfanti P;Rossignol P;Mayaux J;Rieux-Laucat F;Husebye ES;Fusco F;Ursini MV;Imberti L;Sottini A;Paghera S;Quiros-Roldan E;Rossi C;Castagnoli R;Montagna D;Licari A;Marseglia GL;Duval X;Ghosn J;HGID Lab;NIAID-USUHS Immune Response to COVID Group;COVID Clinicians;COVID-STORM Clinicians;Imagine COVID Group;French COVID Cohort Study Group;Milieu Intérieur Consortium;CoV-Contact Cohort;Amsterdam UMC Covid-19 Biobank;COVID Human Genetic Effort;Tsang JS;Goldbach-Mansky R;Kisand K;Lionakis MS;Puel A;Zhang SY;Holland SM;Gorochov G;Jouanguy E;Rice CM;Cobat A;Notarangelo LD;Abel L;Su HC;Casanova JL
通讯作者:
Casanova JL
影响因子:
16.6
作者:
Abela IA;Pasin C;Schwarzmüller M;Epp S;Sickmann ME;Schanz MM;Rusert P;Weber J;Schmutz S;Audigé A;Maliqi L;Hunziker A;Hesselman MC;Niklaus CR;Gottschalk J;Schindler E;Wepf A;Karrer U;Wolfensberger A;Rampini SK;Meyer Sauteur PM;Berger C;Huber M;Böni J;Braun DL;Marconato M;Manz MG;Frey BM;Günthard HF;Kouyos RD;Trkola A
通讯作者:
Trkola A
DOI:
10.1016/j.prostaglandins.2018.09.005
发表时间:
2018-11-01
影响因子:
2.9
作者:
Adili, Reheman;Hawley, Megan;Holinstat, Michael
通讯作者:
Holinstat, Michael
影响因子:
29
作者:
Codo, Ana Campos;Davanzo, Gustavo Gastao;Moraes-Vieira, Pedro M.
通讯作者:
Moraes-Vieira, Pedro M.
影响因子:
2.6
作者:
Chai, Shaoqing;Li, Yan;Xu, Xiaoxiao
通讯作者:
Xu, Xiaoxiao